|
Robert Lawrie (Chair) |
Bretta Maloff Calgary, AB |
|
Rob Assimakopoulos |
Christine McCourt-Reid Edmonton, AB |
| Dr Robert Bell Toronto, ON |
Nancy McKay Fredericton, NB |
|
John Boynton |
James Moore Port Moody, BC |
| Philippe Couillard Saint-Félicien, QC |
Bruce Rothney Toronto, ON |
| Dr. Chen Fong | Valerie Steele Toronto, ON |
| Chan Hon Goh West Vancouver, BC |
Christopher Wein Toronto, ON |
| Dr David Huntsman Vancouver, BC |
Dr Michael Woods St. John's, NL |
| Shachi Kurl Vancouver, BC |
David Woollcombe Toronto, ON |
Board
The Canadian Cancer Society’s national office and each of its provincial offices are accountable to a volunteer board of directors. The board’s responsibilities include governance, leadership, public accountability, establishing the Society’s nation-wide and provincial priorities and acting as a trustee on behalf of Canadians.
-
A message from the Chair of our Board of Directors
Last year the Canadian Cancer Society again improved its financial efficiency. We will announce our third consecutive surplus, while maintaining our level of research investment (~$40 million a year) and other mission support – education, lodges, rides to treatment, wig and prosthesis loans, support and government advocacy. Nearly 1 in 2 Canadians will be diagnosed with cancer in their lifetime. We now know 40% of cancers are preventable, so we are launching a new initiative investing in research to discover and inform Canadians about living healthier lifestyles and we are advocating for government participation. And for those who are diagnosed, the Society will continue to provide support to make their journey less hard.
We also achieved two new strategic initiatives:
- amalgamation with Prostate Cancer Canada, continuing our commitment to consolidate the sector to reduce expense and to dedicate more donor dollars to mission, all to help bring us closer to realizing our vision of a world where no Canadian fears cancer; and
- CDL Cancer from our soon-to-be-opened new Centre for Cancer Prevention and Support in Vancouver. It will be the first venture incubator- accelerator discovering and supporting early-stage science and technology startup ventures focusing on cancer prevention and support and accelerating early-stage ventures’ commercialization in Canada and beyond.
On behalf of the Board of Directors, thank you to our new CEO, Andrea Seale, and our staff; to our donors and volunteers, our work simply would not happen without your support; and to researchers and clinical professionals, you are on the front line giving us strength as you make discoveries and bring comfort as you offer compassionate care. None of this progress would be possible without all of you. Together, we are all a force-for-life in the face of cancer.
Robert Lawrie
